What's going on in today's session
By Mill Chart
Last update: Apr 29, 2024
Monday's session: top gainers and losers
Top losers
| Ticker | Change | Comment |
|---|---|---|
| ANVS | -53.58% | There was a downturn in ANNOVIS BIO's (NYSE:ANVS) shares, as they experienced a 53.58% decline, closing at $8.36 during Monday's session. A press release (Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease) was released earlier today. |
| SWVLW | -29.41% | There was a downturn in PIVOTAL HOLDINGS CORP -CW27's (NASDAQ:SWVLW) shares, as they experienced a 29.41% decline, closing at $0.01 during Monday's session. Shareholders saw the stock price going 57.73% higher in the past 3 months. |
| JAN | -26.67% | JANONE INC's (NASDAQ:JAN) stock price faced a 26.67% decline, reaching $3.74 during Monday's session. In the last month the share price increased with 93.92%. |
| MBIO | -25.66% | There was a notable decline in MUSTANG BIO INC's (NASDAQ:MBIO) shares, as they dropped 25.66% to $0.23 during Monday's session. In the last month the share price dropped with 69.61%. |
| TCJH | -23.71% | Investors witnessed a 23.71% drop in TOP KINGWIN LTD-A's (NASDAQ:TCJH) stock price, which closed at $0.68 during Monday's session. The stock is trading 42.01% lower than a month ago. |
| FTEL | -23.62% | FITELL CORP's (NASDAQ:FTEL) shares fell 23.62% to $6.11. The stock is trading 183.0% higher than 3 months ago. |
| ATXI | -22.18% | AVENUE THERAPEUTICS INC's (NASDAQ:ATXI) stock price faced a 22.18% decline, reaching $4.83 during Monday's session. Earlier today the company had a press release: Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds. |
| CJJD | -18.73% | CHINA JO-JO DRUGSTORES HOLDI's (NASDAQ:CJJD) stock price faced a 18.73% decline, reaching $2.3 during Monday's session. Shareholders saw the stock price going 22.44% lower in the past 3 months. |
| ISUN | -17.56% | ISUN INC's (NASDAQ:ISUN) stock price encountered a 17.56% decline, reaching $0.14 during Monday's session. Shareholders saw the stock price going 32.8% lower in the past month. |
| IONM | -17.46% | The market experienced a 17.46% downturn in ASSURE HOLDINGS CORP's (NASDAQ:IONM) stock price, closing at $0.58 during Monday's session. Shareholders saw the stock price going 42.07% higher in the past month. |
For the full top loser list go to our top losers page.
ANNOVIS BIO
NYSE:ANVS (5/17/2024, 7:04:00 PM)
After market: 8.3 -0.01 (-0.12%)8.31
+0.28 (+3.49%)
ANVS News
20 hours ago - Law Offices of Howard G. SmithINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors
a day ago - Glancy Prongay & Murray LLPGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors
2 days ago - Law Offices of Frank R. CruzThe Law Offices of Frank R. Cruz Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors
5 days ago - InvestorPlaceANVS Stock Earnings: Annovis Bio Beats EPS for Q1 2024ANVS stock results show that Annovis Bio beat analyst estimates for earnings per share the first quarter of 2024.
5 days ago - Annovis Bio Inc.Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial ResultsMALVERN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, provided updates from across the organization and announced first quarter financial results.
9 days ago - ChartmillWhat's going on in today's sessionTop movers analysis one hour before the close of the markets on 2024-05-09: top gainers and losers in today's session.
9 days ago - Annovis Bio Inc.Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s DiseaseMALVERN, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company...
12 days ago - Annovis Bio Inc.Annovis Bio CEO Maria Maccecchini Issues Letter to StockholdersMALVERN, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company...
17 days ago - ChartmillUnusual volume stocks are being observed in Wednesday's session.The trading volume of these stocks is deviating from the norm in today's session.
